AI-generated summary
This protocol describes an ongoing randomised trial comparing an herbal gel containing 2.5% Arrabidaea chica extract with low-level laser therapy for oral mucositis in patients with head and neck cancer. The authors report that results are not yet available, as enrolment began in November 2017 and the study is still in progress.
- Who or what was studied
- Patients with head and neck cancer who develop early signs or symptoms of oral mucositis, treated at the Clinics Hospital of University of Campinas, Sao Paulo.
- Limits stated in the abstract
- This is a study protocol for an ongoing trial, so no efficacy findings are reported yet.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bmjopen.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Oral mucositis, GRADE, Laser, Low-level laser therapy, Trial registration, Wound healing. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.